BioSpace News Archive

Canopy Health announced today an expansion of its collaboration with Health Net.

According to the Massachusetts Department of Public Health, in the first six months of 2019 alone, there were 611 confirmed opioid-related overdose deaths in the Commonwealth – more than three per day.

Invitae Corporation (NYSE: NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of convertible senior notes due 2024 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 29,000 shares of common stock to be distributed among four new employees, with a grant date of September 3, 2019.

First regulatory approval of NERLYNX in Latin America.

All of the shares in the offering are to be sold by TransEnterix.

Vanguard Supports First-of-Its-Kind Project Integrating Home Visiting Nurses into Pediatric Primary Care Setting

Akebia Therapeutics, Inc. granted eight newly-hired employees options to purchase an aggregate of 277,250 shares of Akebia’s common stock on August 30, 2019, including an option to purchase 250,000 shares granted to Steven K. Burke, M.D., Akebia’s newly-hired Senior Vice President, Chief Medical Officer.

Masimo (NASDAQ: MASI) today announced Pathway™, a feature for the Root® Patient Monitoring and Connectivity Platform. Pathway provides clinicians with a way to visualize a hospital’s recommended resuscitation protocol for a newborn’s oxygen saturation (SpO2) while continuously monitoring SpO2 and pulse rate (PR) during the first ten minutes after birth

Includes Unique and Comprehensive Acute Care Diagnostics Portfolio to Enhance Patient Care and Efficiency